Ulobetasol propionate

Clinical data

Trade namesUltravate, Lexette, Bryhali

Other namesHalobetasol propionate, halobetasol propionate (USAN US)

AHFS/Drugs.com

MedlinePlus

Routes of administrationTopical

Drug classCorticosteroid; Glucocorticoid

ATC codeD07AC21 ()

Legal status

Legal statusCA: ℞-only US: ℞-only

Identifiers

IUPAC name [(6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-Chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate

PubChem CID

CompTox Dashboard (EPA)

ECHA InfoCard

Chemical and physical data

FormulaC25H31ClF2O5

Molar mass484.96 g·mol−1

3D model (JSmol)

SMILES CCC(=O)O[C@@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C)C(=O)CCl

InChI InChI=1S/C25H31ClF2O5/c1-5-21(32)33-25(20(31)12-26)13(2)8-15-16-10-18(27)17-9-14(29)6-7-22(17,3)24(16,28)19(30)11-23(15,25)4/h6-7,9,13,15-16,18-19,30H,5,8,10-12H2,1-4H3/t13-,15-,16-,18-,19-,22-,23-,24-,25-/m0/s1Key:BDSYKGHYMJNPAB-LICBFIPMSA-N

Ulobetasol propionate, also known as halobetasol propionate and sold under the brand name Ultravate among others, is a synthetic glucocorticoid corticosteroid and a corticosteroid ester.

It was patented in 1975 and approved for medical use in 1990.